Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Troponin T | 6 | 2017 | 55 | 2.670 |
Why?
|
| Muscle, Skeletal | 13 | 2018 | 493 | 2.360 |
Why?
|
| Aging | 7 | 2017 | 891 | 1.540 |
Why?
|
| Calcium Channels, L-Type | 3 | 2016 | 46 | 1.260 |
Why?
|
| MicroRNAs | 3 | 2017 | 163 | 1.140 |
Why?
|
| Muscle Fibers, Fast-Twitch | 3 | 2017 | 29 | 0.820 |
Why?
|
| Calpain | 2 | 2017 | 12 | 0.760 |
Why?
|
| Cell Nucleus | 4 | 2016 | 99 | 0.750 |
Why?
|
| Exercise Therapy | 2 | 2017 | 209 | 0.650 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 479 | 0.650 |
Why?
|
| Muscle Denervation | 1 | 2017 | 28 | 0.640 |
Why?
|
| Gait | 1 | 2017 | 92 | 0.610 |
Why?
|
| Excitation Contraction Coupling | 1 | 2015 | 8 | 0.570 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2015 | 104 | 0.550 |
Why?
|
| Troponin | 1 | 2015 | 76 | 0.540 |
Why?
|
| Calcium Channels | 1 | 2015 | 55 | 0.540 |
Why?
|
| Mice | 13 | 2018 | 2334 | 0.540 |
Why?
|
| Resistance Training | 1 | 2015 | 68 | 0.520 |
Why?
|
| Apoptosis | 2 | 2013 | 342 | 0.510 |
Why?
|
| Knee Joint | 1 | 2015 | 115 | 0.500 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 54 | 0.500 |
Why?
|
| Pericytes | 4 | 2014 | 27 | 0.490 |
Why?
|
| Muscle Cells | 1 | 2013 | 7 | 0.480 |
Why?
|
| Cell Line | 4 | 2016 | 420 | 0.480 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 112 | 0.470 |
Why?
|
| Animals | 18 | 2018 | 7387 | 0.460 |
Why?
|
| RNA, Messenger | 1 | 2013 | 528 | 0.440 |
Why?
|
| Obesity | 1 | 2017 | 1068 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 709 | 0.370 |
Why?
|
| Laryngeal Muscles | 3 | 2014 | 16 | 0.350 |
Why?
|
| Neuromuscular Junction | 3 | 2018 | 66 | 0.310 |
Why?
|
| Sulfonamides | 2 | 2017 | 67 | 0.300 |
Why?
|
| Muscle Contraction | 2 | 2017 | 112 | 0.290 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 131 | 0.270 |
Why?
|
| Acute Lung Injury | 2 | 2015 | 31 | 0.260 |
Why?
|
| Muscular Atrophy | 4 | 2018 | 68 | 0.230 |
Why?
|
| Flow Cytometry | 2 | 2013 | 172 | 0.220 |
Why?
|
| Antigens | 4 | 2014 | 27 | 0.210 |
Why?
|
| Male | 9 | 2017 | 18242 | 0.210 |
Why?
|
| Proteoglycans | 4 | 2014 | 31 | 0.210 |
Why?
|
| Exercise | 2 | 2017 | 559 | 0.210 |
Why?
|
| Synaptic Transmission | 2 | 2018 | 114 | 0.190 |
Why?
|
| Female | 7 | 2017 | 18466 | 0.190 |
Why?
|
| Receptors, Cholinergic | 1 | 2018 | 22 | 0.180 |
Why?
|
| Physical Conditioning, Animal | 2 | 2017 | 32 | 0.180 |
Why?
|
| Sympathetic Nervous System | 1 | 2018 | 32 | 0.180 |
Why?
|
| Muscle Fibers, Slow-Twitch | 2 | 2016 | 20 | 0.180 |
Why?
|
| Acetylcholine | 1 | 2018 | 40 | 0.180 |
Why?
|
| Wasting Syndrome | 2 | 2015 | 14 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 209 | 0.170 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 5 | 0.170 |
Why?
|
| Cell Differentiation | 3 | 2015 | 422 | 0.170 |
Why?
|
| Aged | 3 | 2017 | 9677 | 0.160 |
Why?
|
| Lipolysis | 1 | 2017 | 15 | 0.160 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2017 | 7 | 0.160 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2017 | 10 | 0.160 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 8 | 0.160 |
Why?
|
| Gene Expression | 3 | 2017 | 329 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 31 | 0.160 |
Why?
|
| Muscle Proteins | 2 | 2015 | 61 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 84 | 0.160 |
Why?
|
| Humans | 8 | 2017 | 29002 | 0.160 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 15 | 0.150 |
Why?
|
| Action Potentials | 1 | 2017 | 167 | 0.150 |
Why?
|
| Muscle Fatigue | 1 | 2016 | 11 | 0.150 |
Why?
|
| Isometric Contraction | 1 | 2016 | 22 | 0.150 |
Why?
|
| Protein Stability | 1 | 2016 | 24 | 0.150 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 3728 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 71 | 0.150 |
Why?
|
| Mice, Transgenic | 5 | 2014 | 241 | 0.140 |
Why?
|
| Protein Binding | 1 | 2016 | 185 | 0.140 |
Why?
|
| Gene Library | 1 | 2015 | 10 | 0.140 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 9 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2015 | 29 | 0.140 |
Why?
|
| Myogenin | 1 | 2014 | 4 | 0.130 |
Why?
|
| Neutrophils | 1 | 2015 | 101 | 0.130 |
Why?
|
| Weight Loss | 1 | 2017 | 405 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2013 | 8 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 64 | 0.130 |
Why?
|
| Myoblasts | 1 | 2014 | 38 | 0.130 |
Why?
|
| Muscle Strength | 1 | 2015 | 130 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 86 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 167 | 0.120 |
Why?
|
| Ischemia | 1 | 2014 | 90 | 0.120 |
Why?
|
| Age Factors | 1 | 2017 | 1129 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 109 | 0.120 |
Why?
|
| Leucine Zippers | 1 | 2013 | 3 | 0.120 |
Why?
|
| Nuclear Localization Signals | 1 | 2013 | 3 | 0.120 |
Why?
|
| Annexin A5 | 1 | 2013 | 7 | 0.120 |
Why?
|
| Adipogenesis | 1 | 2013 | 29 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 47 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 70 | 0.120 |
Why?
|
| Calcium | 1 | 2015 | 301 | 0.120 |
Why?
|
| Body Composition | 1 | 2015 | 359 | 0.120 |
Why?
|
| Biopsy | 1 | 2013 | 240 | 0.120 |
Why?
|
| Levodopa | 1 | 2012 | 12 | 0.120 |
Why?
|
| Reflex | 1 | 2012 | 15 | 0.120 |
Why?
|
| Neuroglia | 1 | 2012 | 34 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2014 | 139 | 0.120 |
Why?
|
| Dopamine Agents | 1 | 2012 | 19 | 0.110 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 30 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 37 | 0.110 |
Why?
|
| Electroporation | 1 | 2011 | 14 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2011 | 53 | 0.110 |
Why?
|
| Extremities | 1 | 2012 | 44 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 80 | 0.110 |
Why?
|
| Staining and Labeling | 1 | 2011 | 56 | 0.110 |
Why?
|
| Regeneration | 1 | 2013 | 165 | 0.110 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 100 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2014 | 785 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 115 | 0.090 |
Why?
|
| Luminescent Proteins | 3 | 2014 | 23 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 576 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2147 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 105 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 2 | 2012 | 9 | 0.060 |
Why?
|
| Cell Lineage | 2 | 2013 | 66 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2014 | 277 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1019 | 0.050 |
Why?
|
| Time Factors | 2 | 2015 | 2034 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2018 | 52 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2017 | 9 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 9 | 0.040 |
Why?
|
| Salivary Glands | 1 | 2017 | 14 | 0.040 |
Why?
|
| Rats | 2 | 2012 | 1701 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 35 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2017 | 139 | 0.040 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2015 | 8 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2015 | 22 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 20 | 0.040 |
Why?
|
| Chemokines | 1 | 2015 | 33 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 682 | 0.030 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2015 | 56 | 0.030 |
Why?
|
| Chromatin | 1 | 2014 | 16 | 0.030 |
Why?
|
| Actins | 1 | 2014 | 53 | 0.030 |
Why?
|
| Vocal Cords | 1 | 2014 | 8 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 74 | 0.030 |
Why?
|
| Hindlimb | 1 | 2014 | 57 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2013 | 2 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 4 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2013 | 35 | 0.030 |
Why?
|
| Fibrosis | 1 | 2013 | 111 | 0.030 |
Why?
|
| Laryngeal Nerves | 1 | 2012 | 4 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2014 | 418 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2012 | 13 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2012 | 133 | 0.030 |
Why?
|
| Species Specificity | 1 | 2012 | 83 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 24 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 57 | 0.030 |
Why?
|
| Motor Activity | 1 | 2015 | 323 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 126 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 664 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 92 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2013 | 175 | 0.030 |
Why?
|
| Reaction Time | 1 | 2012 | 120 | 0.030 |
Why?
|
| Proteomics | 1 | 2012 | 85 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 498 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 202 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 803 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3149 | 0.020 |
Why?
|